223 related articles for article (PubMed ID: 17962944)
1. Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma.
De Geer A; Carlson LM; Kogner P; Levitskaya J
Cancer Immunol Immunother; 2008 May; 57(5):731-43. PubMed ID: 17962944
[TBL] [Abstract][Full Text] [Related]
2. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
3. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
[TBL] [Abstract][Full Text] [Related]
4. Different death stimuli evoke apoptosis via multiple pathways in retinal pigment epithelial cells.
Ferrington DA; Tran TN; Lew KL; Van Remmen H; Gregerson DS
Exp Eye Res; 2006 Sep; 83(3):638-50. PubMed ID: 16682026
[TBL] [Abstract][Full Text] [Related]
5. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
[TBL] [Abstract][Full Text] [Related]
6. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
7. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
[TBL] [Abstract][Full Text] [Related]
8. CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow.
Airoldi I; Cocco C; Morandi F; Prigione I; Pistoia V
Cancer Immunol Immunother; 2008 Apr; 57(4):541-8. PubMed ID: 17786442
[TBL] [Abstract][Full Text] [Related]
9. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis.
Thorpe JA; Christian PA; Schwarze SR
Prostate; 2008 Feb; 68(2):200-9. PubMed ID: 18076022
[TBL] [Abstract][Full Text] [Related]
11. HLA Tetramer Based Artificial Antigen-Presenting Cells Efficiently Stimulate CTLs Specific for Malignant Glioma.
Jiang X; Lu X; Liu R; Zhang F; Zhao H
Clin Cancer Res; 2007 Dec; 13(24):7329-34. PubMed ID: 18094414
[TBL] [Abstract][Full Text] [Related]
12. Expression of markers shared between human haematopoietic cells and neuroblastoma cells.
Ebener U; Wehner S; Cinatl J; Gussetis ES; Kornhuber B
Anticancer Res; 1990; 10(4):887-90. PubMed ID: 2382985
[TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Kawaoka T; Oka M; Takashima M; Ueno T; Yamamoto K; Yahara N; Yoshino S; Hazama S
Oncol Rep; 2008 Jul; 20(1):155-63. PubMed ID: 18575732
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
Lin SJ; Lee CC; Cheng PJ; See LC; Kuo ML
Pediatr Allergy Immunol; 2009 Jun; 20(4):392-8. PubMed ID: 18713315
[TBL] [Abstract][Full Text] [Related]
15. Enhanced effect of IFNgamma on the induced apoptosis of neuroblastoma cells by cytotoxic drugs.
Tong HX; Lu CW; Zhang JH; Zhang JH
Pediatr Hematol Oncol; 2008 Sep; 25(6):549-58. PubMed ID: 18728974
[TBL] [Abstract][Full Text] [Related]
16. Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications.
Raffaghello L; Prigione I; Bocca P; Morandi F; Camoriano M; Gambini C; Wang X; Ferrone S; Pistoia V
Oncogene; 2005 Jul; 24(29):4634-44. PubMed ID: 15897905
[TBL] [Abstract][Full Text] [Related]
17. Topotecan enhances immune clearance of gliomas.
Wei J; DeAngulo G; Sun W; Hussain SF; Vasquez H; Jordan J; Weinberg J; Wolff J; Koshkina N; Heimberger AB
Cancer Immunol Immunother; 2009 Feb; 58(2):259-70. PubMed ID: 18594817
[TBL] [Abstract][Full Text] [Related]
18. Assessment of lymphocyte-mediated cytotoxicity using flow cytometry.
Liu L; Packard BZ; Brown MJ; Komoriya A; Feinberg MB
Methods Mol Biol; 2004; 263():125-40. PubMed ID: 14976364
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocytes induce caspase-dependent and -independent cell death in neuroblastomas in a MHC-nonrestricted fashion.
De Geer A; Kiessling R; Levitsky V; Levitskaya J
J Immunol; 2006 Dec; 177(11):7540-50. PubMed ID: 17114423
[TBL] [Abstract][Full Text] [Related]
20. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
